Sumitomo Group

TMC and Allseas Achieve Historic Milestone: Nodules Collected from the Seafloor and Lifted to the Production Vessel Using 4 km Riser During Pilot Trials in the Clarion Clipperton Zone for First Time Since the 1970s

Retrieved on: 
Wednesday, October 12, 2022

To date on the current campaign the collector vehicle has successfully been test-driven approximately 18.1km within NORI-D.

Key Points: 
  • To date on the current campaign the collector vehicle has successfully been test-driven approximately 18.1km within NORI-D.
  • The assets are designed to record any changes in the marine environment that may occur during testing of the collector system.
  • Once again, our strategic partner Allseas have shown why theyre the best in the business when it comes to pioneering offshore engineering and operations.
  • TMC cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

TMC Subsidiary NORI Commences Monitoring of the Environmental Impacts of Pilot Nodule Collection System Trials in the Clarion-Clipperton Zone

Retrieved on: 
Wednesday, October 5, 2022

The Companys Environmental Program Manager, Dr Michael Clarke, said: Testing of a fully integrated nodule collection system is a landmark event in the progression of our nascent industry.

Key Points: 
  • The Companys Environmental Program Manager, Dr Michael Clarke, said: Testing of a fully integrated nodule collection system is a landmark event in the progression of our nascent industry.
  • Having established a baseline of the NORI-D collector test area, scientists will proceed to monitor the environmental impacts of deployment and testing of the fully integrated nodule collection system.
  • Last month NORI announced that it received the ISAs recommendation to commence its pilot nodule collection system trials in the CCZ after its review of the Environmental Impact Statement (EIS) and Environmental Monitoring and Management Plan (EMMP).
  • Trials of prototype nodule collectors have been successfully conducted by several ISA contractors including BGR and GSR in the recent years.

Sumitomo Chemical forms new business services entity to support the Valent group of companies

Retrieved on: 
Monday, October 3, 2022

Valent North America brings together the Finance, Legal, Environmental, Health & Safety, Information Technology and Human Resources functions to drive strong governance and enhanced service delivery practices more broadly across the Valent group of companies -- Valent U.S.A., Valent BioSciences, Pace International and Mycorrhizal Applications.

Key Points: 
  • Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies.
  • Valent North America brings together the Finance, Legal, Environmental, Health & Safety, Information Technology and Human Resources functions to drive strong governance and enhanced service delivery practices more broadly across the Valent group of companies -- Valent U.S.A. , Valent BioSciences , Pace International and Mycorrhizal Applications .
  • This new operational structure will support our goals of business excellence and growth across North America, said Tadashi Katayama, associate officer and general manager, AgroSolutions Division International, Sumitomo Chemical.
  • Valent is a leader in marketing and sales of both traditional chemical products and biorational products developed by its affiliate, Valent BioSciences LLC.

Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares

Retrieved on: 
Monday, October 3, 2022

Sumitovant currently holds approximately 52% of the outstanding shares of the Company.

Key Points: 
  • Sumitovant currently holds approximately 52% of the outstanding shares of the Company.
  • Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy.
  • Myovant also is conducting a Phase 3 study to evaluate the prevention of pregnancy in women with uterine fibroids or endometriosis.
  • Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Pharma Co., Ltd., is Myovants majority shareholder.

Kenorland Minerals Closes $7.49 M Non-Brokered Private Placement

Retrieved on: 
Monday, September 19, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 19, 2022) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: NWRCF) (FSE: 3WQ0) ("Kenorland" or "the Company") is pleased to announce that it has closed the fully subscribed non-brokered million private placement (the "Placement") of common shares previously announced on September 9, 2022.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 19, 2022) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: NWRCF) (FSE: 3WQ0) ("Kenorland" or "the Company") is pleased to announce that it has closed the fully subscribed non-brokered million private placement (the "Placement") of common shares previously announced on September 9, 2022.
  • The proceeds of the Placement will be utilized to fund the Company's exploration activities on its existing project portfolio and for general working capital.
  • The closing of the Placement is subject to receipt of all necessary regulatory approvals, including the acceptance by the TSXV.
  • The Company paid finder fees of $76,500 in cash to Haywood Securities Inc. in respect of portions of the Placement.

Presidio Ventures Makes Strategic Investment in Ori

Retrieved on: 
Wednesday, September 7, 2022

NEW YORK, Sept. 7, 2022 /PRNewswire/ -- Presidio Ventures, a Sumitomo Corporation of Americas ("SCOA") Group Company, has joined together with existing investors Khosla Ventures, Alphabet, Ingka Investments (of the IKEA Group) and Geolo Capital to participate in Ori's recently closed round of equity financing. Led by South Korean conglomerate, Eugene Group, this funding positions the rapidly growing Boston/NY based startup for expansion in the APAC market.

Key Points: 
  • NEW YORK, Sept. 7, 2022 /PRNewswire/ -- Presidio Ventures, a Sumitomo Corporation of Americas ("SCOA") Group Company, has joined together with existing investors Khosla Ventures, Alphabet, Ingka Investments (of the IKEA Group) and Geolo Capital to participate in Ori's recently closed round of equity financing.
  • Led by South Korean conglomerate, Eugene Group, this funding positions the rapidly growing Boston/NY based startup for expansion in the APAC market.
  • "We're excited by our investment in Ori, which supports Presidio's investment thesis surrounding urban population growth," said Mr. Doug Kuribayashi, CEO of Presidio Ventures.
  • Founded in Sumitomo's centuries-old business philosophy of shared prosperity, Presidio looks for opportunities to partner with entrepreneurs in key industries that shape the way we live.

MetaProp Expands in APAC Region with Appointment of Industry Leader Satoshi Murakami as Director

Retrieved on: 
Wednesday, September 7, 2022

MetaProp the worlds leading venture capital firm focused on the PropTech industrytoday shared plans to accelerate its growth in APAC by appointing Satoshi Murakami as Region Director.

Key Points: 
  • MetaProp the worlds leading venture capital firm focused on the PropTech industrytoday shared plans to accelerate its growth in APAC by appointing Satoshi Murakami as Region Director.
  • As MetaProp grows its presence in the region, the firms planning an APAC Regional Summit for founders and investors to connect with the leadership team.
  • MetaProp is a New York-based venture capital firm focused on the real estate technology (PropTech) industry.
  • Founded in 2015, MetaProps investment team has invested in 175+ technology companies across the real estate value chain.

Taranis Raises $40 Million Series D to Advance Crop Intelligence and Unlock Growth Opportunities for Agribusinesses

Retrieved on: 
Wednesday, September 7, 2022

WESTFIELD, Ind. and TEL AVIV, Israel, Sept. 7, 2022 /PRNewswire/ -- Taranis, the leading AI-powered crop intelligence provider, announced today that it has raised $40 million in Series D funding. The round was led by Inven Capital, a European climate tech fund, with participation from new investors Seraphim Space Investment Trust ('SSIT') and Farglory Group, and strong backing from existing investors: Vertex Growth, Viola Ventures, Vertex Ventures Israel, La Maison Partners, Hitachi Ventures, K3 Ventures, UMC Capital, OurCrowd, Micron Ventures, iAngels Ventures, Presidio Ventures (Sumitomo), Cavallo Ventures (Wilbur Ellis), Finistere Ventures, and Eyal Gura. This latest round brings Taranis' total funding to $100 million.

Key Points: 
  • and TEL AVIV, Israel, Sept. 7, 2022 /PRNewswire/ -- Taranis, the leading AI-powered crop intelligence provider, announced today that it has raised $40 million in Series D funding.
  • Taranis' crop intelligence platform uniquely leverages leaf-level imagery and is powered by cutting-edge machine learning, trained by the industry's largest crop dataset containing over 200 million AI-data points.
  • Technologies that facilitate crop intelligence and agricultural carbon credits such as Taranis' solutions have large-scale potential to improve sustainability and enduring prosperity.
  • It primarily focuses on later-stage growth investment opportunities with a sound business model proven by realized revenues and long-term growth potential.

The Metals Company Subsidiary, NORI, Receives ISA Recommendation to Commence Pilot Nodule Collection Trials in the Clarion Clipperton Zone of the Pacific Ocean

Retrieved on: 
Wednesday, September 7, 2022

Upcoming integrated nodule collection system trials will mark the first such trials to be conducted in the CCZ since the 1970s.

Key Points: 
  • Upcoming integrated nodule collection system trials will mark the first such trials to be conducted in the CCZ since the 1970s.
  • The conclusion of the International Seabed Authoritys review process allows NORI to proceed with its planned integrated pilot collection system trials in its NORI-D exploration contract area in the Clarion Clipperton Zone (CCZ) of the Pacific Ocean.
  • Based upon this feedback and with over 600 comments received, an updated EIS was submitted to the ISA in March 2022.
  • TMC cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Kenorland Announces the Commencement of Exploration and 2022 Budget at the Tanacross Project, Alaska

Retrieved on: 
Wednesday, August 24, 2022

The detailed surveys carried out in 2022, combined with historical datasets will provide fundamental information for drill targeting across multiple target areas.

Key Points: 
  • The detailed surveys carried out in 2022, combined with historical datasets will provide fundamental information for drill targeting across multiple target areas.
  • To view an enhanced version of Figure 1, please visit:
    The total approved budget for the 2022 summer exploration program along with certain fixed costs in 2023, amounts to US$2,000,000.
  • Zach Flood, CEO of Kenorland commented, "We are very excited to be back in Alaska, with Antofagasta, advancing the Tanacross Project towards discovery.
  • The Tanacross Project covers 45,000 hectares of Alaska state-owned land, approximately 70 kilometers northeast of Tok, along the Alaska Highway.